25 XP   0   0   10

Dr. Lal PathLabs Ltd
Buy, Hold or Sell?

Let's analyse Dr. Lal PathLabs Ltd together

PenkeI guess you are interested in Dr. Lal PathLabs Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dr. Lal PathLabs Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dr. Lal PathLabs Ltd

I send you an email if I find something interesting about Dr. Lal PathLabs Ltd.

Quick analysis of Dr. Lal PathLabs Ltd (30 sec.)










What can you expect buying and holding a share of Dr. Lal PathLabs Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.59
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR200.35
Expected worth in 1 year
INR279.56
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR128.75
Return On Investment
5.5%

For what price can you sell your share?

Current Price per Share
INR2,331.00
Expected price per share
INR1,943 - INR2,392
How sure are you?
50%

1. Valuation of Dr. Lal PathLabs Ltd (5 min.)




Live pricePrice per Share (EOD)

INR2,331.00

Intrinsic Value Per Share

INR449.92 - INR619.34

Total Value Per Share

INR650.27 - INR819.69

2. Growth of Dr. Lal PathLabs Ltd (5 min.)




Is Dr. Lal PathLabs Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$199.9m$180.1m$19.7m9.9%

How much money is Dr. Lal PathLabs Ltd making?

Current yearPrevious yearGrowGrow %
Making money$28.6m$41.3m-$12.7m-44.4%
Net Profit Margin11.8%16.5%--

How much money comes from the company's main activities?

3. Financial Health of Dr. Lal PathLabs Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#59 / 145

Most Revenue
#44 / 145

Most Profit
#32 / 145

What can you expect buying and holding a share of Dr. Lal PathLabs Ltd? (5 min.)

Welcome investor! Dr. Lal PathLabs Ltd's management wants to use your money to grow the business. In return you get a share of Dr. Lal PathLabs Ltd.

What can you expect buying and holding a share of Dr. Lal PathLabs Ltd?

First you should know what it really means to hold a share of Dr. Lal PathLabs Ltd. And how you can make/lose money.

Speculation

The Price per Share of Dr. Lal PathLabs Ltd is INR2,331. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dr. Lal PathLabs Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dr. Lal PathLabs Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR200.35. Based on the TTM, the Book Value Change Per Share is INR19.80 per quarter. Based on the YOY, the Book Value Change Per Share is INR30.85 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR12.39 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dr. Lal PathLabs Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.340.0%0.340.0%0.500.0%0.380.0%0.320.0%
Usd Book Value Change Per Share0.240.0%0.240.0%0.370.0%0.250.0%0.300.0%
Usd Dividend Per Share0.150.0%0.150.0%0.170.0%0.140.0%0.100.0%
Usd Total Gains Per Share0.390.0%0.390.0%0.540.0%0.400.0%0.400.0%
Usd Price Per Share27.17-27.17-45.87-25.92-20.35-
Price to Earnings Ratio78.84-78.84-92.20-66.02-60.23-
Price-to-Total Gains Ratio70.34-70.34-85.41-62.47-52.04-
Price to Book Ratio11.30-11.30-21.17-13.60-13.34-
Price-to-Total Gains Ratio70.34-70.34-85.41-62.47-52.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share27.972
Number of shares35
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.150.14
Usd Book Value Change Per Share0.240.25
Usd Total Gains Per Share0.390.40
Gains per Quarter (35 shares)13.5213.84
Gains per Year (35 shares)54.0855.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1213344203645
24267984071100
36210015259107155
48313320679142210
510416626099178265
6125200314119213320
7146233368139249375
8166266422159284430
9187299476178320485
10208333530198356540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%

Fundamentals of Dr. Lal PathLabs Ltd

About Dr. Lal PathLabs Ltd

Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2024-04-14 03:32:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Dr. Lal PathLabs Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dr. Lal PathLabs Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 11.8% means that ₹0.12 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 11.8%. The company is making a huge profit. +2
  • The TTM is 11.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.8%TTM11.8%0.0%
TTM11.8%YOY16.5%-4.7%
TTM11.8%5Y16.1%-4.2%
5Y16.1%10Y16.3%-0.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8%-7.7%+19.5%
TTM11.8%-6.7%+18.5%
YOY16.5%2.4%+14.1%
5Y16.1%-1.5%+17.6%
10Y16.3%-3.4%+19.7%
1.1.2. Return on Assets

Shows how efficient Dr. Lal PathLabs Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • 10.0% Return on Assets means that Dr. Lal PathLabs Ltd generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 10.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY14.7%-4.7%
TTM10.0%5Y15.4%-5.4%
5Y15.4%10Y17.8%-2.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0%-1.7%+11.7%
TTM10.0%-1.3%+11.3%
YOY14.7%-0.9%+15.6%
5Y15.4%-0.5%+15.9%
10Y17.8%-0.9%+18.7%
1.1.3. Return on Equity

Shows how efficient Dr. Lal PathLabs Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • 14.3% Return on Equity means Dr. Lal PathLabs Ltd generated ₹0.14 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 14.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.3%0.0%
TTM14.3%YOY23.0%-8.6%
TTM14.3%5Y20.7%-6.4%
5Y20.7%10Y22.5%-1.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%-0.7%+15.0%
TTM14.3%-0.1%+14.4%
YOY23.0%0.3%+22.7%
5Y20.7%-1.4%+22.1%
10Y22.5%-2.3%+24.8%

1.2. Operating Efficiency of Dr. Lal PathLabs Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dr. Lal PathLabs Ltd is operating .

  • Measures how much profit Dr. Lal PathLabs Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY21.8%-21.8%
TTM-5Y17.2%-17.2%
5Y17.2%10Y16.4%+0.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.2%+6.2%
TTM-0.5%-0.5%
YOY21.8%4.3%+17.5%
5Y17.2%3.7%+13.5%
10Y16.4%-1.3%+17.7%
1.2.2. Operating Ratio

Measures how efficient Dr. Lal PathLabs Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are ₹0.93 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 0.926. The company is less efficient in keeping operating costs low.
  • The TTM is 0.926. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.926TTM0.9260.000
TTM0.926YOY1.034-0.107
TTM0.9265Y1.008-0.081
5Y1.00810Y0.910+0.098
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9261.296-0.370
TTM0.9261.301-0.375
YOY1.0341.238-0.204
5Y1.0081.268-0.260
10Y0.9101.217-0.307

1.3. Liquidity of Dr. Lal PathLabs Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dr. Lal PathLabs Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.07 means the company has ₹2.07 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 2.071. The company is able to pay all its short-term debts. +1
  • The TTM is 2.071. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.071TTM2.0710.000
TTM2.071YOY1.750+0.321
TTM2.0715Y3.561-1.490
5Y3.56110Y4.183-0.621
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0712.111-0.040
TTM2.0712.298-0.227
YOY1.7502.581-0.831
5Y3.5613.012+0.549
10Y4.1833.081+1.102
1.3.2. Quick Ratio

Measures if Dr. Lal PathLabs Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.06 means the company can pay off ₹3.06 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 3.056. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.056. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.056TTM3.0560.000
TTM3.056YOY2.141+0.915
TTM3.0565Y5.369-2.313
5Y5.36910Y5.931-0.562
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0561.204+1.852
TTM3.0561.285+1.771
YOY2.1411.565+0.576
5Y5.3691.925+3.444
10Y5.9312.128+3.803

1.4. Solvency of Dr. Lal PathLabs Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dr. Lal PathLabs Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dr. Lal PathLabs Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.30 means that Dr. Lal PathLabs Ltd assets are financed with 30.2% credit (debt) and the remaining percentage (100% - 30.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 0.302. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.302. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.302TTM0.3020.000
TTM0.302YOY0.360-0.059
TTM0.3025Y0.259+0.043
5Y0.25910Y0.215+0.043
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3020.421-0.119
TTM0.3020.407-0.105
YOY0.3600.394-0.034
5Y0.2590.448-0.189
10Y0.2150.446-0.231
1.4.2. Debt to Equity Ratio

Measures if Dr. Lal PathLabs Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 43.2% means that company has ₹0.43 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dr. Lal PathLabs Ltd:

  • The MRQ is 0.432. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.432. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.432TTM0.4320.000
TTM0.432YOY0.563-0.131
TTM0.4325Y0.363+0.069
5Y0.36310Y0.289+0.073
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4320.606-0.174
TTM0.4320.567-0.135
YOY0.5630.631-0.068
5Y0.3630.658-0.295
10Y0.2890.742-0.453

2. Market Valuation of Dr. Lal PathLabs Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Dr. Lal PathLabs Ltd generates.

  • Above 15 is considered overpriced but always compare Dr. Lal PathLabs Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of 78.84 means the investor is paying ₹78.84 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dr. Lal PathLabs Ltd:

  • The EOD is 81.168. Based on the earnings, the company is expensive. -2
  • The MRQ is 78.835. Based on the earnings, the company is expensive. -2
  • The TTM is 78.835. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD81.168MRQ78.835+2.333
MRQ78.835TTM78.8350.000
TTM78.835YOY92.197-13.361
TTM78.8355Y66.021+12.814
5Y66.02110Y60.227+5.794
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD81.168-0.261+81.429
MRQ78.835-0.409+79.244
TTM78.835-0.341+79.176
YOY92.1970.002+92.195
5Y66.0214.832+61.189
10Y60.2275.198+55.029
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dr. Lal PathLabs Ltd:

  • The EOD is 47.124. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 45.770. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 45.770. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD47.124MRQ45.770+1.354
MRQ45.770TTM45.7700.000
TTM45.770YOY-1,079.575+1,125.345
TTM45.7705Y-174.622+220.392
5Y-174.62210Y-85.796-88.826
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD47.124-0.291+47.415
MRQ45.770-0.441+46.211
TTM45.770-1.388+47.158
YOY-1,079.575-2.079-1,077.496
5Y-174.622-1.446-173.176
10Y-85.796-1.971-83.825
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dr. Lal PathLabs Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 11.30 means the investor is paying ₹11.30 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Dr. Lal PathLabs Ltd:

  • The EOD is 11.635. Based on the equity, the company is expensive. -2
  • The MRQ is 11.300. Based on the equity, the company is expensive. -2
  • The TTM is 11.300. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.635MRQ11.300+0.334
MRQ11.300TTM11.3000.000
TTM11.300YOY21.172-9.872
TTM11.3005Y13.596-2.296
5Y13.59610Y13.337+0.259
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD11.6351.857+9.778
MRQ11.3002.228+9.072
TTM11.3002.222+9.078
YOY21.1723.104+18.068
5Y13.5963.447+10.149
10Y13.3374.036+9.301
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dr. Lal PathLabs Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--19.80219.8020%30.846-36%21.161-6%25.044-21%
Book Value Per Share--200.349200.3490%180.548+11%153.593+30%123.776+62%
Current Ratio--2.0712.0710%1.750+18%3.561-42%4.183-50%
Debt To Asset Ratio--0.3020.3020%0.360-16%0.259+17%0.215+40%
Debt To Equity Ratio--0.4320.4320%0.563-23%0.363+19%0.289+49%
Dividend Per Share--12.38612.3860%13.911-11%11.793+5%8.456+46%
Eps--28.71828.7180%41.461-31%31.250-8%26.403+9%
Free Cash Flow Per Share--49.46549.4650%-3.541+107%26.465+87%22.079+124%
Free Cash Flow To Equity Per Share--15.41615.4160%12.866+20%13.708+12%13.814+12%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--619.340--------
Intrinsic Value_10Y_min--449.923--------
Intrinsic Value_1Y_max--36.114--------
Intrinsic Value_1Y_min--31.479--------
Intrinsic Value_3Y_max--128.283--------
Intrinsic Value_3Y_min--106.926--------
Intrinsic Value_5Y_max--244.295--------
Intrinsic Value_5Y_min--195.326--------
Market Cap193868337600.000+3%188295974400.000188295974400.0000%317924112960.000-41%179725918999.890+5%141110577300.581+33%
Net Profit Margin--0.1180.1180%0.165-28%0.161-26%0.163-27%
Operating Margin----0%0.218-100%0.172-100%0.164-100%
Operating Ratio--0.9260.9260%1.034-10%1.008-8%0.910+2%
Pb Ratio11.635+3%11.30011.3000%21.172-47%13.596-17%13.337-15%
Pe Ratio81.168+3%78.83578.8350%92.197-14%66.021+19%60.227+31%
Price Per Share2331.000+3%2264.0002264.0000%3822.600-41%2159.950+5%1695.813+34%
Price To Free Cash Flow Ratio47.124+3%45.77045.7700%-1079.575+2459%-174.622+482%-85.796+287%
Price To Total Gains Ratio72.419+3%70.33870.3380%85.407-18%62.468+13%52.041+35%
Quick Ratio--3.0563.0560%2.141+43%5.369-43%5.931-48%
Return On Assets--0.1000.1000%0.147-32%0.154-35%0.178-44%
Return On Equity--0.1430.1430%0.230-38%0.207-31%0.225-36%
Total Gains Per Share--32.18832.1880%44.757-28%32.955-2%33.500-4%
Usd Book Value--199955760.000199955760.0000%180192960.000+11%153390456.000+30%123617940.000+62%
Usd Book Value Change Per Share--0.2380.2380%0.370-36%0.254-6%0.301-21%
Usd Book Value Per Share--2.4042.4040%2.167+11%1.843+30%1.485+62%
Usd Dividend Per Share--0.1490.1490%0.167-11%0.142+5%0.101+46%
Usd Eps--0.3450.3450%0.498-31%0.375-8%0.317+9%
Usd Free Cash Flow--49368000.00049368000.0000%-3533880.000+107%26431752.000+87%22050773.925+124%
Usd Free Cash Flow Per Share--0.5940.5940%-0.042+107%0.318+87%0.265+124%
Usd Free Cash Flow To Equity Per Share--0.1850.1850%0.154+20%0.164+12%0.166+12%
Usd Market Cap2326420051.200+3%2259551692.8002259551692.8000%3815089355.520-41%2156711027.999+5%1693326927.607+33%
Usd Price Per Share27.972+3%27.16827.1680%45.871-41%25.919+5%20.350+34%
Usd Profit--28661760.00028661760.0000%41379960.000-31%31210152.000-8%26369486.250+9%
Usd Revenue--242025840.000242025840.0000%250488960.000-3%197263944.000+23%164699247.735+47%
Usd Total Gains Per Share--0.3860.3860%0.537-28%0.395-2%0.402-4%
 EOD+4 -4MRQTTM+0 -0YOY+16 -195Y+17 -1810Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Dr. Lal PathLabs Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1581.168
Price to Book Ratio (EOD)Between0-111.635
Net Profit Margin (MRQ)Greater than00.118
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.056
Current Ratio (MRQ)Greater than12.071
Debt to Asset Ratio (MRQ)Less than10.302
Debt to Equity Ratio (MRQ)Less than10.432
Return on Equity (MRQ)Greater than0.150.143
Return on Assets (MRQ)Greater than0.050.100
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Dr. Lal PathLabs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.925
Ma 20Greater thanMa 502,276.237
Ma 50Greater thanMa 1002,282.271
Ma 100Greater thanMa 2002,409.662
OpenGreater thanClose2,253.300
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Other Stockholders Equity  251,24049,610300,85068,010368,860184,690553,550-558,150-4,600



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets23,855,620
Total Liabilities7,192,640
Total Stockholder Equity16,662,980
 As reported
Total Liabilities 7,192,640
Total Stockholder Equity+ 16,662,980
Total Assets = 23,855,620

Assets

Total Assets23,855,620
Total Current Assets9,730,850
Long-term Assets14,125,000
Total Current Assets
Cash And Cash Equivalents 135,230
Short-term Investments 5,505,760
Net Receivables 708,000
Inventory 355,320
Other Current Assets 151,730
Total Current Assets  (as reported)9,730,850
Total Current Assets  (calculated)6,856,040
+/- 2,874,810
Long-term Assets
Property Plant Equipment 4,040,000
Goodwill 5,478,410
Intangible Assets 3,581,900
Other Assets 672,560
Long-term Assets  (as reported)14,125,000
Long-term Assets  (calculated)13,772,870
+/- 352,130

Liabilities & Shareholders' Equity

Total Current Liabilities4,697,530
Long-term Liabilities2,162,000
Total Stockholder Equity16,662,980
Total Current Liabilities
Short-term Debt 700,040
Short Long Term Debt 1,533,000
Accounts payable 1,561,000
Other Current Liabilities 316,000
Total Current Liabilities  (as reported)4,697,530
Total Current Liabilities  (calculated)4,110,040
+/- 587,490
Long-term Liabilities
Long term Debt Total 2,133,230
Long-term Liabilities  (as reported)2,162,000
Long-term Liabilities  (calculated)2,133,230
+/- 28,770
Total Stockholder Equity
Common Stock833,680
Retained Earnings 15,017,550
Capital Surplus 934,880
Other Stockholders Equity -4,600
Total Stockholder Equity (as reported)16,662,980
Total Stockholder Equity (calculated)16,781,510
+/- 118,530
Other
Capital Stock834,000
Cash And Equivalents2,502,080
Cash and Short Term Investments 8,143,070
Common Stock Shares Outstanding 82,941
Liabilities and Stockholders Equity 23,855,620
Net Invested Capital 19,029,000
Net Working Capital 5,032,000
Property Plant and Equipment Gross 4,040,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
5,511,100
6,900,900
9,155,480
10,905,000
13,743,060
16,613,300
23,467,510
23,855,620
23,855,62023,467,51016,613,30013,743,06010,905,0009,155,4806,900,9005,511,100
   > Total Current Assets 
3,651,520
4,665,570
6,230,160
8,136,310
8,926,460
11,451,700
8,751,510
9,730,850
9,730,8508,751,51011,451,7008,926,4608,136,3106,230,1604,665,5703,651,520
       Cash And Cash Equivalents 
93,240
135,000
458,000
1,056,620
1,846,360
261,530
209,720
135,230
135,230209,720261,5301,846,3601,056,620458,000135,00093,240
       Short-term Investments 
0
3,276,708
4,351,510
5,442,360
5,350,240
7,397,270
3,034,600
5,505,760
5,505,7603,034,6007,397,2705,350,2405,442,3604,351,5103,276,7080
       Net Receivables 
429,550
486,980
508,440
711,610
513,880
667,010
853,950
708,000
708,000853,950667,010513,880711,610508,440486,980429,550
       Inventory 
168,390
179,070
273,350
285,350
569,600
425,580
525,410
355,320
355,320525,410425,580569,600285,350273,350179,070168,390
       Other Current Assets 
84,770
542,430
836,130
329,220
221,160
191,970
206,630
151,730
151,730206,630191,970221,160329,220836,130542,43084,770
   > Long-term Assets 
0
2,535,487
2,958,650
2,768,690
4,816,600
5,162,000
14,780,690
14,125,000
14,125,00014,780,6905,162,0004,816,6002,768,6902,958,6502,535,4870
       Property Plant Equipment 
1,057,390
1,235,580
1,693,520
1,635,550
3,021,020
3,176,220
4,448,510
4,040,000
4,040,0004,448,5103,176,2203,021,0201,635,5501,693,5201,235,5801,057,390
       Goodwill 
115,950
278,770
279,170
279,740
772,260
853,600
5,434,350
5,478,410
5,478,4105,434,350853,600772,260279,740279,170278,770115,950
       Intangible Assets 
137,370
185,080
198,180
205,740
450,700
595,080
4,105,570
3,581,900
3,581,9004,105,570595,080450,700205,740198,180185,080137,370
       Long-term Assets Other 
0
116,654
1,360
1,560
760
15,000
-148,450
14,000
14,000-148,45015,0007601,5601,360116,6540
> Total Liabilities 
845,490
945,720
1,277,000
1,450,040
3,414,980
4,162,710
8,451,430
7,192,640
7,192,6408,451,4304,162,7103,414,9801,450,0401,277,000945,720845,490
   > Total Current Liabilities 
763,310
848,380
1,159,580
1,383,040
2,273,070
2,742,850
4,999,880
4,697,530
4,697,5304,999,8802,742,8502,273,0701,383,0401,159,580848,380763,310
       Short-term Debt 
0
0
0
0
0
0
954,230
700,040
700,040954,230000000
       Short Long Term Debt 
0
0
0
0
0
0
1,788,530
1,533,000
1,533,0001,788,530000000
       Accounts payable 
0
523,760
654,510
798,000
1,177,350
1,441,280
1,473,840
1,561,000
1,561,0001,473,8401,441,2801,177,350798,000654,510523,7600
       Other Current Liabilities 
0
194,010
346,150
408,290
516,940
670,720
847,320
316,000
316,000847,320670,720516,940408,290346,150194,0100
   > Long-term Liabilities 
0
283,247
79,530
12,170
929,720
1,110,000
3,096,950
2,162,000
2,162,0003,096,9501,110,000929,72012,17079,530283,2470
       Long term Debt Total 
0
0
0
0
929,720
1,102,750
3,056,560
2,133,230
2,133,2303,056,5601,102,750929,7200000
       Other Liabilities 
0
72,950
79,530
12,170
0
7,550
40,390
0
040,3907,550012,17079,53072,9500
> Total Stockholder Equity
4,665,610
5,955,180
7,878,480
9,454,960
10,328,080
12,450,590
15,016,080
16,662,980
16,662,98015,016,08012,450,59010,328,0809,454,9607,878,4805,955,1804,665,610
   Common Stock
826,770
830,660
833,330
833,420
833,450
833,450
833,450
833,680
833,680833,450833,450833,450833,420833,330830,660826,770
   Retained Earnings 
3,408,590
4,570,690
6,260,430
7,720,330
8,507,060
10,520,360
12,927,540
15,017,550
15,017,55012,927,54010,520,3608,507,0607,720,3306,260,4304,570,6903,408,590
   Capital Surplus 
867,600
899,860
926,730
927,620
927,950
927,950
927,950
934,880
934,880927,950927,950927,950927,620926,730899,860867,600
   Treasury Stock00-200,030-241,230-277,650-292,430-435,820-437,350
   Other Stockholders Equity 
0
89,790
150,420
251,240
300,850
368,860
553,550
-4,600
-4,600553,550368,860300,850251,240150,42089,7900



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue21,227,000
Cost of Revenue-4,681,000
Gross Profit16,546,00016,546,000
 
Operating Income (+$)
Gross Profit16,546,000
Operating Expense-14,346,000
Operating Income6,881,0002,200,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense14,346,0000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-339,000
Other Finance Cost-0
Net Interest Income-339,000
 
Pretax Income (+$)
Operating Income6,881,000
Net Interest Income-339,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,294,0006,881,000
EBIT - interestExpense = -339,000
3,014,000
3,353,000
Interest Expense339,000
Earnings Before Interest and Taxes (EBIT)-4,633,000
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax4,294,000
Tax Provision-1,246,000
Net Income From Continuing Ops3,048,0003,048,000
Net Income3,014,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-339,000
 

Technical Analysis of Dr. Lal PathLabs Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dr. Lal PathLabs Ltd. The general trend of Dr. Lal PathLabs Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dr. Lal PathLabs Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dr. Lal PathLabs Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2,255 < 2,359 < 2,392.

The bearish price targets are: 2,004 > 1,945 > 1,943.

Tweet this
Dr. Lal PathLabs Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dr. Lal PathLabs Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dr. Lal PathLabs Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dr. Lal PathLabs Ltd. The current macd is 9.83919808.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dr. Lal PathLabs Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dr. Lal PathLabs Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dr. Lal PathLabs Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Dr. Lal PathLabs Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDr. Lal PathLabs Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dr. Lal PathLabs Ltd. The current adx is 19.65.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Dr. Lal PathLabs Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Dr. Lal PathLabs Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dr. Lal PathLabs Ltd. The current sar is 2,363.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Dr. Lal PathLabs Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dr. Lal PathLabs Ltd. The current rsi is 56.92. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Dr. Lal PathLabs Ltd Daily Relative Strength Index (RSI) ChartDr. Lal PathLabs Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dr. Lal PathLabs Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dr. Lal PathLabs Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dr. Lal PathLabs Ltd Daily Stochastic Oscillator ChartDr. Lal PathLabs Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dr. Lal PathLabs Ltd. The current cci is 77.01.

Dr. Lal PathLabs Ltd Daily Commodity Channel Index (CCI) ChartDr. Lal PathLabs Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dr. Lal PathLabs Ltd. The current cmo is 20.10.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Dr. Lal PathLabs Ltd Daily Chande Momentum Oscillator (CMO) ChartDr. Lal PathLabs Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dr. Lal PathLabs Ltd. The current willr is -27.3297491.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Dr. Lal PathLabs Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Dr. Lal PathLabs Ltd Daily Williams %R ChartDr. Lal PathLabs Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dr. Lal PathLabs Ltd.

Dr. Lal PathLabs Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dr. Lal PathLabs Ltd. The current atr is 64.36.

Dr. Lal PathLabs Ltd Daily Average True Range (ATR) ChartDr. Lal PathLabs Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dr. Lal PathLabs Ltd. The current obv is 954,243.

Dr. Lal PathLabs Ltd Daily On-Balance Volume (OBV) ChartDr. Lal PathLabs Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dr. Lal PathLabs Ltd. The current mfi is 66.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Dr. Lal PathLabs Ltd Daily Money Flow Index (MFI) ChartDr. Lal PathLabs Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dr. Lal PathLabs Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Dr. Lal PathLabs Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dr. Lal PathLabs Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.925
Ma 20Greater thanMa 502,276.237
Ma 50Greater thanMa 1002,282.271
Ma 100Greater thanMa 2002,409.662
OpenGreater thanClose2,253.300
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dr. Lal PathLabs Ltd with someone you think should read this too:
  • Are you bullish or bearish on Dr. Lal PathLabs Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dr. Lal PathLabs Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dr. Lal PathLabs Ltd

I send you an email if I find something interesting about Dr. Lal PathLabs Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dr. Lal PathLabs Ltd.

Receive notifications about Dr. Lal PathLabs Ltd in your mailbox!